| Levy P
Bile acid sequestrants as a therapeutic option for glucose lowering in type 2 diabetes mellitus. [Journal Article]
Endocr Pract 2008 Jul-Aug; 14(5):644-7.
Full Citation | Find Related Articles |
| Bays HE, Goldberg RB
The 'forgotten' bile acid sequestrants: is now a good time to remember? [Journal Article, Review]
Am J Ther 2007 Nov-Dec; 14(6):567-80.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Staels B, Kuipers F
Bile Acid Sequestrants and the Treatment of Type 2 Diabetes Mellitus. [JOURNAL ARTICLE]
Drugs 2007; 67(10):1383-1392.
Abstract | Full Citation |
| Jacobson TA, Armani A, McKenney JM, et al.
Safety considerations with gastrointestinally active lipid-lowering drugs. [Journal Article]
Am J Cardiol 2007 Mar 19; 99(6A):S47-55.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Zambon A, Brown BG, Hokanson JE, et al.
Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy. [Journal Article, Randomized Controlled Trial]
J Intern Med 2006 Apr; 259(4):401-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Insull W
Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review. [Journal Article, Review]
South Med J 2006 Mar; 99(3):257-73.
Abstract | Full Citation | Find Related Articles |
| Weinhofer I, Kunze M, Rampler H, et al.
Liver X receptor alpha interferes with SREBP1c-mediated Abcd2 expression. Novel cross-talk in gene regulation. [Journal Article]
J Biol Chem 2005 Dec 16; 280(50):41243-51.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Complementary care. How statin alternatives stack up. Some help control cholesterol; others are potentially harmful. [Journal Article]
Heart Advis 2005 Jan; 8(1):4-5.
Full Citation | Find Related Articles |
| Ritter MM
A bitter tale. [Comment, Letter]
N Engl J Med 2005 Jan 6; 352(1):97-8; author reply 97-8.
Full Citation | Find Related Articles |
| Bilheimer DW, Grundy SM, Brown MS, et al.
Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholeserolemia heterozygotes. 1983. [Biography, Classical Article, Historical Article, Journal Article]
Atheroscler Suppl 2004 Oct; 5(3):61-5.
Full Citation | Publisher Full Text | Find Related Articles |
  |
